These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23671288)

  • 21. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
    Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
    J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating insulin-like growth factor (IGF)-I and IGF binding proteins -1 and -3 and placental development in the guinea-pig.
    Roberts CT; Kind KL; Earl RA; Grant PA; Robinson JS; Sohlstrom A; Owens PC; Owens JA
    Placenta; 2002 Nov; 23(10):763-70. PubMed ID: 12398816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis.
    Street ME; Ziveri MA; Spaggiari C; Viani I; Volta C; Grzincich GL; Virdis R; Bernasconi S
    Eur J Endocrinol; 2006 Jan; 154(1):47-52. PubMed ID: 16381990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
    Frystyk J; Grønbaek H; Skjaerbaek C; Flyvbjerg A; Orskov H; Baxter RC
    Endocrinology; 1998 Oct; 139(10):4286-92. PubMed ID: 9751511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging.
    Wennberg AMV; Hagen CE; Petersen RC; Mielke MM
    Exp Gerontol; 2018 Jun; 106():67-73. PubMed ID: 29474865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of insulin-like growth factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle-aged and young athletes versus sedentary men: relationship with glucose disposal.
    Manetta J; Brun JF; Fedou C; Maïmoun L; Prefaut C; Mercier J
    Metabolism; 2003 Jul; 52(7):821-6. PubMed ID: 12870155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
    Teixeira RJ; Silva VC; Gazolla HM; Cunha SB; Guimarães MM
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):69-75. PubMed ID: 11826868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight.
    Vatten LJ; Ødegård RA; Nilsen ST; Salvesen KA; Austgulen R
    Obstet Gynecol; 2002 Jan; 99(1):85-90. PubMed ID: 11777516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 Levels in healthy elderly individuals. Relation to self-reported quality of health and disability.
    Janssen JA; Stolk RP; Pols HA; Grobbee DE; Lamberts SW
    Gerontology; 1998; 44(5):277-80. PubMed ID: 9693259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.